Call me naive,,,,,,,,,,,,,,
My initial reaction to the failed partnership was "the partner" was making unrealistic demands. I am no longer as sure of that and now feel there is a strong possibility it is GTCB that is being tough. LEO has clearly done its dew dilligence (sp) on DIC and as noted when you put the pathophysiology with the clinical this is a very tight case. No doubt LEO and GTCB talk. I think management knows what they have and are willing to slow play their hand for awhile.
Does LEO trade???
Market Data 
Markets 
